FORMOSA LABORATORIES INC TAIWAN

Business Nature: Manufacturer

Company Profile:

Formosa Laboratories Inc. is a prominent pharmaceutical company based in Taiwan, specializing in the research, development, and manufacturing of Active Pharmaceutical Ingredients (APIs) and high-value chemical products. The company is widely recognized for its expertise in complex synthesis and high-potency drug manufacturing. It operates state-of-the-art production facilities that comply with international quality standards, including FDA and PIC/S GMP certifications. Formosa Laboratories focuses on providing high-quality pharmaceutical solutions to global markets, maintaining a strong emphasis on innovation, regulatory compliance, and advanced technical capabilities in the life sciences sector.

FORMOSA LABORATORIES INC TAIWAN manufactures and sells the following products and services:

Active Pharmaceutical Ingredients (APIs):

Antiviral APIs including Tenofovir Disoproxil Fumarate, Lamivudine, Emtricitabine, Adefovir Dipivoxil, and Entecavir.

Anti-Cancer APIs including Capecitabine, Gemcitabine HCl, and Pemetrexed Disodium.

Cardiovascular APIs including Valsartan, Olmesartan Medoxomil, and Candesartan Cilexetil.

Central Nervous System (CNS) APIs including Pregabalin.

Anti-Diabetic APIs including Sitagliptin Phosphate Monohydrate.

Other APIs including Lurasidone HCl.

Finished Dosage Forms (FDFs):

Development and manufacturing of various finished pharmaceutical products on a contract basis for pharmaceutical companies.

Contract Development and Manufacturing Organization (CDMO) Services:

API process development and optimization, pilot plant production, and commercial manufacturing services adhering to cGMP standards.